Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...

Florida Cancer Specialists & Research Institute, LLC (FCS) is among the first oncology providers in Florida selected to ...

Many men with low levels could be spared from invasive procedures and frequent testing ...

– 32nd Annual Scientific Retreat brought together 600+ prostate cancer researchers and leaders to spotlight breakthrough discoveries and advance cutting-edge science – – PCF continues to be the ...

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, abiraterone.

Doctors say paying attention to subtle bodily changes could play a crucial role in detecting prostate cancer earlier.